Return to TA324 Overview

Dual‑chamber pacemakers for symptomatic bradycardia due to sick sinus syndrome without atrioventricular block [TA324]

Measuring the use of this guidance

Recommendation: 1.1

Dual‑chamber pacemakers are recommended as an option for treating symptomatic bradycardia due to sick sinus syndrome without atrioventricular block.

What was measured: The percentage of atrial‐based pacing implants as a proportion of all new implants for Sick Sinus Syndrome.
Data collection end: March 2015
89.4%
Area covered: UK
Source: National Institute for Cardiovascular Outcomes Research. National Audit of Cardiac Rhythm Management.

What was measured: Proportion of dual-chamber pacemaker implants for the management of sick sinus syndrome which were documented to meet NICE guidance for this indication.
Data collection end: March 2016
94%
Area covered: UK
Source: National Institute for Cardiovascular Outcomes Research. National Audit of Cardiac Rhythm Management.



 Return to TA324 Overview